Advertisement

Topics

FDA Approves MabPlex\'s IND

04:36 EST 16 Jan 2019 | Contract Pharma

MabPlex was contracted to develop and manufacture the product from cell line development to IND filing in both the United States and China

Original Article: FDA Approves MabPlex\'s IND

NEXT ARTICLE

More From BioPortfolio on "FDA Approves MabPlex\'s IND"

Advertisement
Quick Search
Advertisement
Advertisement